Lido Advisors
ABBV icon

Lido Advisors’s AbbVie ABBV Stock Holding History

Lido Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.41M Buy
15,700
+7,000
+80% +$1.55M 0.01% 545
2025
Q4 		$1.99M Hold
8,700
– – 0.01% 726
2025
Q3 		$2.01M Buy
8,700
+1,400
+19% +$285K 0.01% 685
2025
Q2 		$1.36M Buy
7,300
+2,300
+46% +$427K 0.01% 722
2025
Q1 		$1.05M Hold
5,000
– – ﹤0.01% 761
2024
Q4 		$889K Sell
5,000
-2,100
-30% -$386K ﹤0.01% 805
2024
Q3 		$1.4M Hold
7,100
– – 0.01% 584
2024
Q2 		$1.22M Sell
7,100
-7,600
-52% -$1.26M 0.01% 581
2024
Q1 		$2.68M Hold
14,700
– – 0.02% 377
2023
Q4 		$2.28M Hold
14,700
– – 0.02% 388
2023
Q3 		$2.19M Buy
14,700
+2,100
+17% +$308K 0.02% 359
2023
Q2 		$1.7M Sell
12,600
-400
-3% -$58.7K 0.01% 405
2023
Q1 		$2.07M Hold
13,000
– – 0.02% 336
2022
Q4 		$2.1M Sell
13,000
-4,500
-26% -$690K 0.03% 288
2022
Q3 		$2.35M Buy
17,500
+4,500
+35% +$646K 0.03% 233
2022
Q2 		$1.99M Sell
13,000
-100
-0.8% -$15.3K 0.03% 236
2022
Q1 		$2.12M Sell
13,100
-200
-2% -$29.1K 0.02% 252
2021
Q4 		$1.8M Hold
13,300
– – 0.02% 296
2021
Q3 		$1.43M Hold
13,300
– – 0.02% 324
2021
Q2 		$1.5M Sell
13,300
-100
-0.7% -$11.3K 0.02% 305
2021
Q1 		$1.45M Buy
13,400
+5,200
+63% +$556K 0.03% 276
2020
Q4 		$878K Sell
8,200
-900
-10% -$86.5K 0.02% 342
2020
Q3 		$797K Hold
9,100
– – 0.02% 302
2020
Q2 		$893K Sell
9,100
-3,000
-25% -$264K 0.03% 257
2020
Q1 		$921K Hold
12,100
– – 0.04% 239
2019
Q4 		$1.07M Hold
12,100
– – 0.04% 250
2019
Q3 		$916K Hold
12,100
– – 0.05% 234
2019
Q2 		$879K Buy
12,100
+6,000
+98% +$472K 0.05% 210
2019
Q1 		$491K Buy
+6,100
New +$499K 0.03% 290

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lido Advisors's ABBV Position: Q1 2026 in Review

Lido Advisors increased its AbbVie (ABBV) stake by 2.7% in Q1 2026, buying an estimated $2.51M and bringing the position to 432,465 shares worth $94.1M. The position accounts for 0.29% of the portfolio, ranked #57.

Lido Advisors first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $97.4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Lido Advisors held 432,465 shares of AbbVie worth $94.1M as of Q1 2026.
  • Lido Advisors bought 11,334 AbbVie shares in Q1 2026, an estimated $2.51M.
  • AbbVie made up 0.29% of Lido Advisors's portfolio in Q1 2026, its #57 holding.
  • Lido Advisors first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
  • Lido Advisors's AbbVie position peaked at $97.4M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.